202 related articles for article (PubMed ID: 2015101)
1. Amiodarone- and desethylamiodarone-induced pulmonary phospholipidosis, inhibition of phospholipases in vivo, and alteration of [14C]amiodarone uptake by perfused lung.
Kodavanti UP; Mehendale HM
Am J Respir Cell Mol Biol; 1991 Apr; 4(4):369-78. PubMed ID: 2015101
[TBL] [Abstract][Full Text] [Related]
2. Amiodarone-induced phospholipidosis in rat alveolar macrophages.
Reasor MJ; Ogle CL; Walker ER; Kacew S
Am Rev Respir Dis; 1988 Mar; 137(3):510-8. PubMed ID: 2830811
[TBL] [Abstract][Full Text] [Related]
3. Influence of a pre-existing phospholipidosis on the accumulation of amiodarone and desethylamiodarone in rat alveolar macrophages.
Reasor MJ
Res Commun Chem Pathol Pharmacol; 1991 May; 72(2):169-81. PubMed ID: 1876748
[TBL] [Abstract][Full Text] [Related]
4. Amiodarone toxicity. II. Desethylamiodarone-induced phospholipidosis and ultrastructural changes during repeated administration in rats.
Kannan R; Sarma JS; Guha M; Venkataraman K
Fundam Appl Toxicol; 1991 Jan; 16(1):103-9. PubMed ID: 2019335
[TBL] [Abstract][Full Text] [Related]
5. The induction of pulmonary phospholipidosis and the inhibition of lysosomal phospholipases by amiodarone.
Heath MF; Costa-Jussà FR; Jacobs JM; Jacobson W
Br J Exp Pathol; 1985 Aug; 66(4):391-7. PubMed ID: 2992568
[TBL] [Abstract][Full Text] [Related]
6. Response of rat lungs to amiodarone: preferential accumulation of amiodarone and desethylamiodarone in alveolar macrophages.
Reasor MJ; Ogle CL; Miles PR
Exp Lung Res; 1990; 16(6):577-91. PubMed ID: 2081504
[TBL] [Abstract][Full Text] [Related]
7. Effects of vitamin E on cytotoxicity of amiodarone and N-desethylamiodarone in isolated hamster lung cells.
Bolt MW; Racz WJ; Brien JF; Massey TE
Toxicology; 2001 Sep; 166(3):109-18. PubMed ID: 11543907
[TBL] [Abstract][Full Text] [Related]
8. Silymarin and vitamin E reduce amiodarone-induced lysosomal phospholipidosis in rats.
Agoston M; Orsi F; Fehér E; Hagymási K; Orosz Z; Blázovics A; Fehér J; Vereckei A
Toxicology; 2003 Aug; 190(3):231-41. PubMed ID: 12927377
[TBL] [Abstract][Full Text] [Related]
9. Disruption of mitochondrial function and cellular ATP levels by amiodarone and N-desethylamiodarone in initiation of amiodarone-induced pulmonary cytotoxicity.
Bolt MW; Card JW; Racz WJ; Brien JF; Massey TE
J Pharmacol Exp Ther; 2001 Sep; 298(3):1280-9. PubMed ID: 11504831
[TBL] [Abstract][Full Text] [Related]
10. Comparative evaluation of amiodarone-induced phospholipidosis and drug accumulation in Fischer-344 and Sprague-Dawley rats.
Reasor MJ; McCloud CM; Beard TL; Ebert DC; Kacew S; Gardner MF; Aldern KA; Hostetler KY
Toxicology; 1996 Jan; 106(1-3):139-47. PubMed ID: 8571385
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary sequestration of amiodarone and desethylamiodarone.
Camus P; Mehendale HM
J Pharmacol Exp Ther; 1986 Jun; 237(3):867-73. PubMed ID: 3712283
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic interaction between amiodarone and desethylamiodarone in human peripheral lung epithelial cells.
Roth FC; Mulder JE; Brien JF; Takahashi T; Massey TE
Chem Biol Interact; 2013 Aug; 204(3):135-9. PubMed ID: 23707191
[TBL] [Abstract][Full Text] [Related]
13. X-ray microanalysis of cultured alveolar macrophages with phospholipidosis.
Lee P; Kirk RG; Reasor MJ
Exp Mol Pathol; 1993 Apr; 58(2):96-104. PubMed ID: 8388333
[TBL] [Abstract][Full Text] [Related]
14. In vitro inhibition of lysosomal phospholipase A1 of rat lung by amiodarone and desethylamiodarone.
Hostetler KY; Giordano JR; Jellison EJ
Biochim Biophys Acta; 1988 Apr; 959(3):316-21. PubMed ID: 3355852
[TBL] [Abstract][Full Text] [Related]
15. Vitamin E reduces accumulation of amiodarone and desethylamiodarone and inhibits phospholipidosis in cultured human cells.
Honegger UE; Scuntaro I; Wiesmann UN
Biochem Pharmacol; 1995 Jun; 49(12):1741-5. PubMed ID: 7598736
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone pulmonary toxicity: biochemical evidence for a cellular phospholipidosis in the bronchoalveolar lavage of human subjects.
Martin WJ; Standing JE
J Pharmacol Exp Ther; 1988 Feb; 244(2):774-9. PubMed ID: 3346847
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.
Wilson BD; Lippmann ML
Am Rev Respir Dis; 1990 Jun; 141(6):1553-8. PubMed ID: 2350098
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of phospholipidosis in amiodarone pulmonary toxicity.
Martin WJ; Kachel DL; Vilen T; Natarajan V
J Pharmacol Exp Ther; 1989 Oct; 251(1):272-8. PubMed ID: 2795460
[TBL] [Abstract][Full Text] [Related]
19. Acute silica toxicity: attenuation by amiodarone-induced pulmonary phospholipidosis.
Antonini JM; McCloud CM; Reasor MJ
Environ Health Perspect; 1994 Apr; 102(4):372-8. PubMed ID: 7925177
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of amiodarone and desethylamiodarone cytotoxicity in nontransformed human peripheral lung epithelial cells.
Mulder JE; Brien JF; Racz WJ; Takahashi T; Massey TE
J Pharmacol Exp Ther; 2011 Feb; 336(2):551-9. PubMed ID: 21078785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
